NAMPT inhibitors are compounds that specifically target nicotinamide phosphoribosyltransferase, an enzyme crucial for NAD+ biosynthesis, used in research to explore metabolic pathways, cellular energy production, and potential therapeutic interventions in diseases like cancer and inflammation.